Mindray Introduces Optimizer™ Suite for A7 Anesthesia Workstation

Share Article

Optimizer Suite supports low flow anesthesia with real time monitoring of anesthetic agent; to be showcased at the American Association of Nurse Anesthetists Annual Congress

“Mindray continues to grow and has become a leader in the OR, not only with patient monitoring, but also anesthesia delivery and point-of-care ultrasound solutions. A continuing stream of innovative technologies have helped build that leadership.”

Shenzhen Mindray Bio-Medical Electronics Co., Ltd (Mindray) today formally introduced the expanded Optimizer™ suite of functionality for the A7 Anesthesia Workstation to the North American market at the American Association of Nurse Anesthetists (AANA) Annual Congress in Washington, DC. The Optimizer suite, standard on the A7, supports real time monitoring of anesthetic agent use during the OR procedure, assists in minimizing agent waste, and provides end-of-case consumption calculations. The user interface is integrated into the A7’s standard 15” touchscreen display for ease of access and use.

Mindray continues to innovate anesthesia technologies to meet the demands in the operating room environment. The anesthesia machine is fundamental for the anesthesia provider. This robust suite of capabilities on the A7 can not only assist the staff in potentially reducing anesthetic agent usage and waste but can also help protect the environment from harmful emissions. The new features can also help to improve clinical workflow to positively affect process efficiencies and can support cost reduction initiatives in the operating room (OR).
In addition to the A7, Mindray will also be featuring its new Passport Series monitors, including the Passport 17m designed to meet the requirements of the high acuity OR. The Passport 17m supports the innovative T1 Transport Monitor/Module, which provides the ability to monitor the patient continuously from pre-op through the post-op environments, minimizing patient cables changes and speeding workflow while helping to ensure continuous monitoring.

Mindray’s leadership in point-of-care ultrasound will also be highlighted with the TE7 Touch-Enabled Ultrasound System with live scanning during the meetings. Unlike many POC systems, the TE7 cuts the clutter with no keyboard, supporting rapid assessment, needle placement with iNeedle™ optimized visualization, and pain management with intuitive gestures. Simply select a focused exam preset and relevant functions become accessible: Tap to open or close functions, drag to adjust parameters or move objects, pinch to zoom in or out, slide for selections, and even swipe to expand the image – all with the touch of a finger.

“Mindray continues to grow and has become a leader in the OR, not only with patient monitoring, but also anesthesia delivery and point-of-care ultrasound solutions. A continuing stream of innovative technologies have helped build that leadership,” said Wayne Quinn, President of Mindray North America. “Clinicians who have worked with Mindray solutions have been impressed with the intuitive operation and comprehensive functionality available across multiple modalities. The OR allows us to showcase all of our solutions – coming together to meet the needs of the anesthesia provider.”

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China, North American headquarters in Mahwah, New Jersey, and multiple development facilities and offices in major international markets. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Peter Collins
PC Media Relations LLC
+1 (908) 499-1200
Email >
Follow us on
Visit website